Active Surveillance May Benefit Men With Low-Risk Prostate Cancer
Study: Bone drug boosts breast cancer survival
WEDNESDAY, Dec. 7 (HealthDay News) -- As more men are screened for and diagnosed with low-risk prostate cancer, a new draft report released Wednesday by a U.S. National Institutes of Health panel concluded that research on the safety of "active surveillance" is needed. read more..
source:http://yhoo.it/ru2v7F
Study: Bone drug boosts breast cancer survival
Doctors were mostly hoping to prevent complications and relapses when they gave young women a medicine to keep their bones strong during breast cancer treatment. Seven years later, they found it did more than that: The bone drug improved survival, as much as many chemotherapies do. read more..
source:http://yhoo.it/rUudFH
No comments:
Post a Comment